Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indivior PLC

www.indivior.com

Latest From Indivior PLC

US FDA May Change Opioid Labeling To Limit Dispensing By Indication

Commissioner Gottlieb says FDA is looking to work with provider groups to set dosage based on indication; Patrick Kennedy is calling on CMS to provide reimbursement for opioid addiction treatment.

Risk Management Private Payers

Indivior To Appeal US Suboxone Setback, Flags Follow-On Drug RBP-6000

Shares in Indivior slid nearly 40% on news of a US court ruling which raises chances its key opioid addiction treatment may face generic competition sooner than expected.

Business Strategies Companies

Pipeline Watch: Phase II Readouts With SPK-8011, Velusetrag, GBR-830

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Approvals Pipeline Watch

Keeping Track: Merck's Follow-On Insulin Edges Closer To Market; Braeburn Submits Another Buprenorphine Depot

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Review Pathway
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Reckitt Benckiser Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Indivior PLC
  • Senior Management
  • Shaun Thaxter, CEO
    Cary Claiborne, CFO
    Tim Baxter, MD, CMO
    Tony Goodman, Chief Bus. Dev. Officer
    Christian Heidbreder, PhD, CSO
    Richard Simkin, Chief Commercial Officer
  • Contact Info
  • Indivior PLC
    Phone: (0)1753 217800
    215 Bath Rd.
    Slough, SL1 4AA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register